HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xanthogranulomatous pyelonephritis complicating crizotinib treatment of an ALK-rearranged non-small-cell lung cancer.

AuthorsS Brosseau, V Gounant, L Choudat, J Pluvy, G Zalcman, A Khalil
JournalDiagnostic and interventional imaging (Diagn Interv Imaging) Vol. 99 Issue 4 Pg. 267-268 (Apr 2018) ISSN: 2211-5684 [Electronic] France
PMID29472032 (Publication Type: Case Reports, Letter)
Chemical References
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridines
  • Crizotinib
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Receptor Protein-Tyrosine Kinases
Topics
  • Anaplastic Lymphoma Kinase
  • Carcinoma, Non-Small-Cell Lung (drug therapy, genetics)
  • Crizotinib
  • Gene Rearrangement
  • Humans
  • Lung Neoplasms (drug therapy, genetics)
  • Male
  • Middle Aged
  • Protein Kinase Inhibitors (administration & dosage, adverse effects)
  • Pyelonephritis, Xanthogranulomatous (chemically induced)
  • Pyrazoles (administration & dosage, adverse effects)
  • Pyridines (administration & dosage, adverse effects)
  • Receptor Protein-Tyrosine Kinases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: